ClinicalTrials.gov
public full text
Public Domain
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
bipolar-disordernapsychiatric-disordersquality-of-lifeschizoaffective-disorderschizophreniaserious-mental-illness
The goal of this study is to reduce Anticholinergic Medication (ACM) in persons with psychoses or serious mental illness, when these medications are no longer needed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Impact of Anticholinergic Burden on the Development of Mild Behavioral Impairment#485291
- Antipsychotic co-medication and treatment response to rTMS and iTBS in depression: Data from clinical records from two independent clinical sites.#301570
- Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia#886738
- Alteraciones de las funciones cognitvas en pacientes con trastorno bipolar: revisión sistemática de evidencias en estudios transversales#945236
- A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials#848825
Record · ID 877310
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive